Takayasu’s arteritis is a rare inflammatory condition that damages the body’s largest arteries, making it crucial to detect the disease early before serious complications develop. Understanding when to seek testing and what diagnostic methods doctors use can help patients receive the proper care they need to manage this lifelong condition.

Who Should Undergo Diagnostics and When

If you are experiencing certain symptoms or belong to specific groups, it may be time to consider getting tested for Takayasu’s arteritis. This condition often begins quietly, which is why knowing when to seek medical attention is so important.

Young women under the age of 40 should pay particular attention to their symptoms, as this group is most commonly affected by the disease. The condition shows a strong preference for women, occurring nine times more often in women than in men. People of Asian, Mexican, or Mediterranean descent are also at higher risk, though the disease can affect anyone worldwide.^[1][2]

Early symptoms can be vague and easy to overlook. If you experience ongoing tiredness that doesn’t improve with rest, unexplained weight loss, mild fever that comes and goes, or persistent muscle and joint aches, these could be early warning signs. Many people feel generally unwell during this initial phase, sometimes with night sweats accompanying the fever. Because these symptoms are not specific to Takayasu’s arteritis, many individuals don’t seek medical help right away, which can delay diagnosis.^[1][2]

As the disease progresses, more specific symptoms may develop that should prompt immediate medical attention. If you notice that your arms feel weak or painful when you use them repeatedly, such as while brushing your hair or carrying groceries, this could indicate reduced blood flow. Pain in your legs when walking that goes away with rest, known as claudication, is another important sign. Dizziness when standing up, persistent headaches, or changes in your vision should never be ignored.^[2]

One particularly telling sign is when doctors have difficulty finding your pulse in your wrists or arms, or when they notice a significant difference in blood pressure between your left and right arms. This is why Takayasu’s arteritis is sometimes called “pulseless disease.” If you already know you have high blood pressure and you’re under 40 with no clear explanation, this unusual finding warrants investigation.^[2][4]

Certain unusual symptoms should also raise suspicion. Neck pain along the path of your carotid arteries, unusual sounds that your doctor can hear through a stethoscope over your arteries (called bruits), inflammation of the white part of your eye, or skin conditions like erythema nodosum (tender red bumps on the legs) may all be connected to this disease.^[4][13]

Classic Diagnostic Methods

Diagnosing Takayasu’s arteritis requires a combination of approaches because no single test can definitively confirm the disease. Doctors must piece together information from your medical history, physical examination, blood tests, and imaging studies to reach a diagnosis. This can sometimes be challenging because the condition is rare and can mimic other diseases.^[3]

Clinical Evaluation and Physical Examination

Your doctor will begin with a thorough conversation about your symptoms and a careful physical examination. During the exam, they will check your pulses at multiple locations including your wrists, elbows, neck, and feet. Finding weak or absent pulses is a significant clue. They will also measure your blood pressure in both arms, as a difference of 20 millimeters of mercury or more between the two arms is an important finding.^[8][9]

Using a stethoscope, your doctor will listen for unusual sounds over your arteries. These sounds, called bruits, occur when blood flow becomes turbulent as it passes through narrowed vessels. The doctor may hear a harsh, whooshing sound over your carotid arteries in the neck, your abdominal arteries, or other large blood vessels. Tenderness over affected arteries when pressed is another sign doctors look for during the physical examination.^[4]

Blood Tests

Blood tests cannot diagnose Takayasu’s arteritis directly, but they help detect inflammation in your body and rule out other conditions. The most commonly used blood tests measure inflammatory markers. Your doctor will check your erythrocyte sedimentation rate, often shortened to ESR or “sed rate,” which measures how quickly red blood cells settle at the bottom of a test tube. When inflammation is present, this rate increases.^[9]

Another important test measures C-reactive protein, or CRP, which rises rapidly when inflammation occurs anywhere in your body. During the active, inflammatory phase of Takayasu’s arteritis, most patients show elevated levels of these markers. However, it’s important to understand that these tests are not specific to Takayasu’s arteritis, as many other conditions can cause similar elevations.^[4][9]

Blood tests may also reveal anemia, which means you have too few red blood cells. This commonly occurs with chronic inflammatory diseases. Additionally, doctors may check kidney function tests and other blood work to assess whether the disease has affected other organs.^[9]

Imaging Studies

Imaging studies form the backbone of Takayasu’s arteritis diagnosis because they can actually show the damage to arteries. Several different types of imaging may be used, each with its own advantages.

Angiography was historically the gold standard for diagnosing Takayasu’s arteritis. During this procedure, a doctor inserts a long, thin, flexible tube called a catheter into a large artery or vein, usually in your groin or arm. A special contrast dye flows through the catheter, and X-ray images are taken as the dye fills your arteries. The images clearly show if blood flow is normal or if it’s slowed or blocked by narrowed vessels. People with Takayasu’s arteritis typically have multiple areas of narrowing, called stenosis. The images may also reveal irregular, “corkscrew” patterns or areas where arteries have become dilated.^[4][9]

Magnetic Resonance Angiography, or MRA, offers a less invasive alternative to traditional angiography. This test uses powerful magnets and radio waves to create detailed images of your blood vessels without requiring catheters or X-rays. During an MRA, you lie inside a large tube-shaped machine while it creates cross-sectional images of your tissues. A contrast dye injected into your vein helps your healthcare professional see the blood vessels more clearly. MRA can show not just narrowing but also inflammation in the artery walls themselves, which makes it particularly useful for Takayasu’s arteritis.^[9][16]

Computed Tomography Angiography, known as CT angiography or CTA, combines computer processing of X-ray images with contrast dye injected into a vein or artery. This test allows doctors to examine your aorta and its nearby branches in detail and observe how blood flows through them. CT angiography is faster than MRA and provides excellent images of the vessel walls and any calcium deposits that may be present.^[9][12]

Doppler ultrasound represents an advanced version of regular ultrasound. It uses sound waves to create images and can also show how blood moves through your vessels. This test is completely painless and doesn’t use radiation or contrast dye. It works particularly well for examining the carotid arteries in your neck and can detect changes in the thickness of artery walls. Doctors can also use ultrasound to measure blood flow velocity, which decreases when arteries narrow.^[9][16]

Classification Criteria

To help standardize diagnosis, medical organizations have developed classification criteria. According to the American College of Rheumatology and European Alliance of Associations for Rheumatology, absolute requirements for classification include being age 60 or younger at diagnosis and having evidence of inflammation in the aorta or its branch arteries confirmed by imaging. Additional factors are assigned points based on symptoms and findings, such as female sex, limb claudication, arterial bruits, reduced pulses, blood pressure differences between arms, and specific patterns of arterial involvement. A cumulative score of 5 points or more has been shown to identify Takayasu’s arteritis with high accuracy.^[8]

Doctors also classify Takayasu’s arteritis into six types based on which arteries are affected. Type I involves branches of the aortic arch in the chest. Type IIa affects the ascending aorta, aortic arch, and branches, while Type IIb extends down to include the thoracic descending aorta. Type III impacts the thoracic descending aorta, abdominal aorta, and renal arteries. Type IV involves the abdominal aorta and renal arteries. Finally, Type V affects the entire aorta and all its branches. This classification helps doctors predict complications and plan treatment.^[8]

Tissue Biopsy

While rarely performed, a tissue biopsy involves removing a small sample of the affected artery wall for examination under a microscope. This can show the characteristic pattern of inflammation seen in Takayasu’s arteritis, including granulomatous inflammation, which involves specific types of immune cells forming small clusters. However, because biopsies require surgery and carry risks, doctors usually rely on the combination of clinical findings and imaging studies instead.^[3][12]

Diagnostics for Clinical Trial Qualification

When patients with Takayasu’s arteritis consider participating in clinical trials testing new treatments, they must undergo additional testing beyond standard diagnostic procedures. Clinical trials require very specific criteria to ensure patient safety and that results can be accurately interpreted.

Most clinical trials for Takayasu’s arteritis require confirmation of the diagnosis through imaging studies, typically using CT angiography, MRA, or traditional angiography. These images document the extent and location of arterial involvement at the start of the trial. Researchers need this baseline information to later determine whether an experimental treatment has helped, worsened, or had no effect on the disease.^[8]

Blood tests measuring disease activity play a crucial role in trial qualification. Trials testing anti-inflammatory medications often require elevated levels of inflammatory markers like ESR or CRP at the time of enrollment. This ensures that participants have active disease that could potentially respond to treatment. Some trials specify exact levels these markers must reach for a patient to qualify.^[4]

Assessment of disease activity involves more than just blood tests and images. Clinical trials often use standardized questionnaires and examination forms to document symptoms like claudication, blood pressure differences, pulse deficits, and bruits. These assessments create a comprehensive picture of how the disease affects each participant at the beginning of the study.^[8]

Some trials require documentation of previous treatments and their effects. For example, a study testing a new medication might only accept patients who have already tried corticosteroids with incomplete success. The trial team needs detailed records of what medications you’ve taken, at what doses, for how long, and what your response was. This information helps researchers understand whether the experimental treatment works for patients who haven’t responded to standard therapies.^[11]

Additional screening tests ensure participant safety during the trial. These typically include comprehensive blood work to check kidney function, liver function, blood cell counts, and screening for infections like tuberculosis or hepatitis. Because many treatments for Takayasu’s arteritis suppress the immune system, trials need to ensure participants don’t have active infections that could become dangerous during treatment. Women of childbearing age may need pregnancy tests, as some experimental medications could harm a developing baby.^[11]

Cardiac evaluation often forms part of the screening process for clinical trials. This may include an electrocardiogram (EKG), which records the electrical activity of your heart, and possibly an echocardiogram, which uses ultrasound to examine your heart’s structure and function. These tests help identify any heart complications from Takayasu’s arteritis and ensure the experimental treatment won’t pose cardiovascular risks.^[2]

Throughout a clinical trial, participants undergo repeated testing at scheduled intervals. These monitoring visits typically include the same imaging studies, blood tests, and clinical assessments performed at enrollment. This repeated testing allows researchers to track whether the disease is improving, staying stable, or worsening over time. The frequency of testing varies by trial but often occurs every few months during the active treatment phase.^[11]

Some specialized trials may use advanced imaging techniques not commonly available in regular clinical practice. These might include special MRI sequences that can measure inflammation intensity in artery walls or positron emission tomography (PET) scans that show metabolic activity in inflamed tissues. While these technologies provide valuable research information, they’re not typically necessary for standard diagnosis or treatment monitoring.^[8]